Ahmed Ali
Internal Medicine · Las Vegas, NVNPI 1700247657
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Intuitive Surgical at 37.2% of the total. Reporting peaked in 2021 at $99 and has fallen 69.4% since, to $30 in 2025. That places this record below the midpoint for internal medicine clinicians in NV, where the typical reported total is $253.
Across 11 payments — averaging $24.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$99
- Novo Nordisk$35
- Beone Medicines USA, Inc.$30
- E.r. Squibb & Sons, L.L.C.$23
- Amgen$21
- Mylan Specialty L.p.$16
- plus $41 from 3 others
What the payments were for
- Food & beverage$266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $99 |
| Novo Nordisk | 2 | $35 |
| Beone Medicines USA, Inc. | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $23 |
| Amgen | 1 | $21 |
| Mylan Specialty L.p. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $14 |
| Johnson & Johnson | 1 | $11 |
How this compares
$266 in reported general payments places this provider in the 50th percentile of 1,071 internal medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $26,933 |
| MounjaroTirzepatide | 17 | $17,802 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $1,335 |
| Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm | 11 | $965 |
| Atorvastatin Calcium | 90 | $796 |
| Ventolin HfaAlbuterol Sulfate | 13 | $755 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $567 |
| Levothyroxine Sodium | 55 | $471 |
| Fluticasone Propionate | 25 | $454 |
| Duloxetine Hcl | 27 | $438 |
| Losartan Potassium | 44 | $426 |
| Amlodipine Besylate | 57 | $404 |
| Oxycodone Hcl | 14 | $382 |
| Alprazolam | 48 | $335 |
| Tamsulosin Hcl | 42 | $333 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Las Vegas
- Kevin DunsmoorLas Vegas$241K
- Robert ChiascioneLas Vegas$174K
- Dino GonzalezLas Vegas$126K
- Rosanne SugayLas Vegas$63K
- Chad HallLas Vegas$42K
- Zubin DamaniaLas Vegas$40K
- Audrey Sue CruzLas Vegas$34K
- Bashab BanerjiLas Vegas$26K
- Amaan ShafiLas Vegas$25K
- Sassan KavehLas Vegas$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.